CJC 1295 (NO DAC) 5mg+ IPA 5mg

CJC-1295 (NO DAC) 5mg + IPAMORELIN 5mg

Overview

CJC-1295 (No DAC) + Ipamorelin is a dual-peptide research formulation supplied for use in controlled laboratory environments. This combination is commonly utilized in studies involving growth hormone–related signaling and peptide-receptor interactions.

Research Context

• CJC-1295 (No DAC) is studied for its interaction with growth hormone–releasing hormone (GHRH) receptors
• Ipamorelin is studied as a selective agonist of ghrelin receptors (GHS-R1a)

This combination is frequently used to explore coordinated signaling within endocrine research models.

Applications in Research Settings

• Growth hormone signaling pathways
• Peptide-receptor interaction studies
• Endocrine system modeling
• Metabolic and regulatory processes

Specifications

• Form: Lyophilized powder
• Container: Research vial
• Appearance: White powder

Storage

Store refrigerated at 2–8°C (36–46°F). Protect from light. Avoid repeated temperature fluctuations.

Disclaimer

For research use only. Not for human or clinical use.